Old Web
English
Sign In
Acemap
>
Paper
>
IMMU-09. CONCURRENT DEXAMETHASONE LIMITS THE CLINICAL BENEFIT OF IMMUNE CHECKPOINT BLOCKADE IN GLIOBLASTOMA
IMMU-09. CONCURRENT DEXAMETHASONE LIMITS THE CLINICAL BENEFIT OF IMMUNE CHECKPOINT BLOCKADE IN GLIOBLASTOMA
2020
Bryan Iorgulescu
Prafulla C. Gokhale
Maria C. Speranza
Benjamin K. Eschle
Michael J. Poitras
Margaret K. Wilkens
Kara M Soroko
Chhayheng Chhoeu
Aine Knott
Yang Gao
Mary Jane Lim-Fat
Gregory L. Baker
Dennis M. Bonal
Quang-Dé Nguyen
Gareth Grant
Keith L. Ligon
Peter K. Sorger
E. Antonio Chiocca
Ana C. Anderson
Paul Kirschmeier
Arlene H. Sharpe
Gordon J. Freeman
David A. Reardon
Keywords:
Immune checkpoint
Glioblastoma
Blockade
Dexamethasone
Cancer research
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]